P&G Makes Proteomics Debut in Licensing Deal with APBiotech | GenomeWeb

NEW YORK, Dec 19 - Amersham Pharmacia Biotech said Tuesday that it had agreed to exclusively license a technology from Procter & Gamble that would increase the percentage of proteins and peptides that can be identified using APB’s Ettan MALDI-ToF mass spectrometry analysis system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.